Correction: The HDAC inhibitor, MPT0E028, enhances erlotinib induced cell death in EGFR-TKI-resistant NSCLC cells.

Chen, M -C; Chen, C -H; Wang, J -C; Tsai, A -C; Liou, J -P; Pan, S -L; Teng, C -M

Chen, M -C; Chen, C -H; Wang, J -C; Tsai, A -C; Liou, J -P; Pan, S -L; Teng, C -M.

Afiliación

Chen M-; Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chen C-; Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan.
Wang J-; The PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Tsai A-; Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan.
Liou J-; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan. jpl@tmu.edu.tw.
Pan S-; The PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. slpan@tmu.edu.tw.
Teng C-; Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan. cmteng@ntu.edu.tw.

Cell Death Dis ; 15(7): 490, 2024 Jul 09.

Article en En | MEDLINE | ID: mdl-38982073

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cell Death Dis Año: 2024 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google